Kelsey Goodwin
Stock Analyst at Piper Sandler
(4.73)
Main Sectors:
Top Industries:
15 Stocks
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
SMMT Summit Therapeutics | Initiates Coverage On: Neutral | 21 | 21.49 | -2.28% | 1 | Aug 19, 2025 | |
JANX Janux Therapeutics | Initiates Coverage On: Overweight | 42 | 24.04 | 74.71% | 1 | Aug 19, 2025 | |
RVMD Revolution Medicines | Initiates Coverage On: Overweight | 75 | 46.72 | 60.53% | 1 | Aug 19, 2025 | |
URGN UroGen Pharma | Initiates Coverage On: Overweight | 36 | 17.4 | 106.9% | 4 | Aug 19, 2025 | |
CGON CG Oncology | Initiates Coverage On: Overweight | 55 | 39.85 | 38.02% | 1 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 11 | 7.76 | 41.75% | 1 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 112 | 84.22 | 32.99% | 3 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 36 | 17.01 | 111.64% | 1 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | n/a | n/a | n/a | 3 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 8 | 4.45 | 79.78% | 1 | Oct 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 4 | Sep 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | n/a | n/a | n/a | 3 | Jun 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | n/a | n/a | n/a | 1 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | n/a | n/a | n/a | 1 | Oct 31, 2022 |